APOA1 and invasive breast carcinoma: In a cohort study, among 38,823 Norwegian women aged 17–54 years (follow-up: 17.2 years, 708 cases of invasive breast cancer identified), no link between apoA and postmenopausal breast cancer risk was found [16].